SEC Form 4 · accession 0001209191-18-022128

SURMODICS INC · SRDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior VP of Bus Dev, Med Dev

Period of report

Mar 27, 2018

Accepted (ET)

Mar 29, 2018 · 6:08 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000924717

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 27, 2018	M	21,469	$12.40	A	59,774	D
Common Stock	Mar 27, 2018	F	13,720	$37.60	D	46,054	D
Common Stock	Mar 28, 2018	M	13,266	$20.37	A	59,320	D
Common Stock	Mar 28, 2018	M	12,612	$22.58	A	71,932	D
Common Stock	Mar 28, 2018	F	19,705	$38.20	D	52,227	D
Common Stock	holding	—	—		—	800	I	By IRA

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Employee Stock Option (right to buy)^F1	$12.40	Mar 27, 2018	M	21,469	D	—	Nov 30, 2018	Common Stock	21,469	D
Employee Stock Option (right to buy)^F1	$20.37	Mar 28, 2018	M	13,266	D	—	Dec 12, 2019	Common Stock	13,266	D
Employee Stock Option (right to buy)^F1	$22.58	Mar 28, 2018	M	12,612	D	—	Nov 18, 2020	Common Stock	12,612	D